Lüder Hinrich Meyer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Mitochondrial Dna

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Stefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, Vera Muench, Daniel Tews, Ulrich Rupp, Eugen Tausch, Alexander Groß, Pamela Fischer-Posovszky, Paul Walther, Stephan Stilgenbauer, Hans Armin Kestler, Klaus-Michael Debatin, Lüder Hinrich Meyer
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation. Cell death & disease 15 (7) (2024)
Stefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, Vera Muench, Daniel Tews, Ulrich Rupp, Eugen Tausch, Alexander Groß, Pamela Fischer-Posovszky, Paul Walther, Stephan Stilgenbauer, Hans Armin Kestler, Klaus-Michael Debatin, Lüder Hinrich Meyer
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation. Cell death & disease 15 (7) (2024)
Stefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, Vera Muench, Daniel Tews, Ulrich Rupp, Eugen Tausch, Alexander Groß, Pamela Fischer-Posovszky, Paul Walther, Stephan Stilgenbauer, Hans Armin Kestler, Klaus-Michael Debatin, Lüder Hinrich Meyer
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation. Cell death & disease 15 (7) (2024)
Felix Seyfried, Felix Uli Stirnweiß, Alexandra Niedermayer, Stefanie Enzenmüller, Rebecca Louise Hörl, Vera Münch, Stefan Köhrer, Klaus-Michael Debatin, Lüder Hinrich Meyer
Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALL. Leukemia 36 (4) (2022)